Tumor Subtype Determines Therapeutic Response to Chimeric Polypeptide Nanoparticle-based Chemotherapy in Pten-deleted Mouse Models of Sarcoma.
Rebecca D DoddAmanda SchererWesley HuangGavin R McGivneyWade R GutierrezEmily A LavertyKathleen A AshcraftVictoria R StephensParisa YousefpourSoumen SahaVickie Knepper-AdrianWarren FloydMark ChenYan MaEric M MastriaDiana M CardonaWilliam C EwardAshutosh ChilkotiDavid G KirschPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)
These results have important implications for treating sarcomas with nanoparticle-encapsulated chemotherapy by highlighting the tumor subtype-dependent nature of therapeutic response.